Fibrin knob-hole interface

The fibrin knob-hole interface is the primary structural mechanism for the assembly of fibrin monomers into a stable fibrin polymer during blood coagulation (Weisel, 2005, Adv Protein Chem). This process begins when thrombin cleaves fibrinopeptides A and B from fibrinogen, exposing N-terminal 'knobs' (A and B) that then dock into complementary 'holes' (a and b) located in the C-terminal domains of neighboring fibrin molecules (Kostelansky et al., 2002, Biochemistry). This interaction is essential for the formation of protofibrils and the subsequent branching and lateral thickening of the fibrin network. As a therapeutic target, the interface is exploited to develop anticoagulants that inhibit clot formation by physically blocking these binding pockets, rather than targeting the enzymatic activity of thrombin or Factor Xa. Research into small molecules and peptides that mimic these knobs aims to provide a more controlled method of preventing thrombosis while potentially reducing the risk of excessive bleeding associated with traditional anticoagulants (Litvinov et al., 2005, JBC). These inhibitors, such as GPRP-based peptides, compete with the natural knobs for the hole sites, effectively halting the polymerization process at the monomeric or protofibril stage. This target is particularly relevant for conditions where pathological fibrin deposition occurs, such as in deep vein thrombosis or ischemic stroke. Understanding the biophysics of this interface allows for the design of agents that can modulate clot density and permeability, offering a nuanced approach to thrombolytic therapy.

Other names

Fibrin polymerization interfaceFibrinogen knob-hole interactionA:a and B:b interactionsFibrin assembly site

Competitive inhibition of fibrin monomer polymerization by binding to the 'hole' pockets (pockets 'a' and 'b') in the gamma and beta nodules of fibrinogen/fibrin, thereby preventing the assembly of the fibrin mesh (Litvinov et al., 2005, JBC).